Behfar Ehdaie

365 posts

Behfar Ehdaie banner
Behfar Ehdaie

Behfar Ehdaie

@BehfarEhdaieMD

Associate Professor Surgery @MSKCancerCenter | BA @UVA | MD @Georgetown | MPH @Harvard | Husband | Father | Mentor *Opinions expressed are my own*

New York, USA Katılım Aralık 2013
213 Takip Edilen697 Takipçiler
Behfar Ehdaie
Behfar Ehdaie@BehfarEhdaieMD·
@marthpodi @ChiUroSociety Thank you to the @ChiUroSociety for an engaging evening of multidisciplinary presentations and insightful discussion in an elegant setting. Dr Belfield was a true pioneer and giant in medicine.
English
1
0
1
97
Parth K. Modi
Parth K. Modi@marthpodi·
Great to have Dr. Behfar Ehdaie give the annual Belfield lecture at @ChiUroSociety tonight. Full house and great discussions!
Parth K. Modi tweet mediaParth K. Modi tweet media
English
1
0
10
749
Dipen J Parekh, M.D.
Dipen J Parekh, M.D.@dipenjparekh·
We are so fortunate to have @gonzomdphd lead and shine ✨ 👏🔥👌❤️
Miller Medicine@umiamimedicine

Join us in celebrating @gonzomdphd, M.D., Ph.D., M.B.A., as he steps into his new role as Chair of the Department of Urology @dsui_miami_uro and @umiamimedicine! 🩺 A nationally recognized leader in urologic care, research, and education, Dr. Gonzalgo will oversee and lead clinical, research, and educational programs in urology—advancing our mission in alignment with the vision of the Desai Sethi Urology Institute, under the leadership of founding director @dipenjparekh, M.D., who is also chief executive officer of UHealth and executive vice president of health affairs for the @Univmiami. We are proud to have such a visionary guiding the future of urology at UHealth and the Miller School. 🙌 Learn more: loom.ly/UqduYlc

English
7
7
84
5.7K
Behfar Ehdaie
Behfar Ehdaie@BehfarEhdaieMD·
Come join us for hopefully an engaging and balanced AUA Course reviewing key concepts in prostate cancer focal therapy. Distinguished faculty discuss their experience and reveal advanced techniques using all focal therapy technology in a lively case-based format #AUA25
Behfar Ehdaie tweet media
English
2
3
21
3.3K
Behfar Ehdaie retweetledi
Dr Andre Abreu
Dr Andre Abreu@ALDCAbreu·
The inaugural Masterclass in Robotic HIFU for Prostate Cancer is only one day away! We are excited to have focal therapy experts Pierre Halteh, MD, @AmirLebastchi, MD, @BehfarEhdaieMD and Pr. Sebastien Crouzet share their personal experience. @USC_Urology @FocalOneHIFU
English
0
3
12
699
Behfar Ehdaie
Behfar Ehdaie@BehfarEhdaieMD·
@jimhumd @seanmmcbride Some additional thoughts: most patients’ data classified as outcome failure are low vol GG2 (MR- invisible) in the opposite hemigland (not dx on initial bx); & patients have option to resume AS. We are preparing 5-yr tx failure data to provide more counseling info for physicians
English
1
0
5
236
Jim Hu
Jim Hu@jimhumd·
@seanmmcbride I counsel using this evidence. FT incontinence and ED better than RP. Some opt for FT for functional outcomes over cancer control. Of note, our 43% 2-yr focal therapy treatment failure is similar to @BehfarEhdaieMD 40% for in bore HIFU, which had more restrictive entry criteria pic.twitter.com/XBwn4roXjw
English
5
3
8
1.7K
Scott Eggener
Scott Eggener@uroegg·
History repeats itself....... Prostate Cancers in the Prostate-specific Antigen Interval of 1.8–3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial - European Urology europeanurology.com/article/S0302-…
English
1
7
30
6.3K
Sean McBride
Sean McBride@seanmmcbride·
Thrilled that @HimanshuNagarMD will be coming to @MSKCancerCenter to lead our GU Radiation Oncology team. He's a brilliant clinical trialist, an outstanding clinician, and someone with an impressive track record of mentoring and cross-disciplinary collaboration. We're very lucky! #radonc #pcsm @DrRosenbergMSK @morr316 @BehfarEhdaieMD @UrologyMSK #MedTwitter
Memorial Sloan Kettering Radiation Oncology@MSK_RadOnc

📢We are overjoyed to announce that Dr @HimanshuNagarMD will be joining @MSKCancerCenter this summer as our Genitourinary Cancer Disease site leader. Dr Nagar is a compassionate clinician & innovative researcher. We are excited to see where he leads our GU #radonc team!

English
9
6
101
11.1K
Behfar Ehdaie
Behfar Ehdaie@BehfarEhdaieMD·
Come join us for hopefully an engaging and balanced AUA Course reviewing the role of focal therapy in prostate cancer & translating the outcomes of clinical trials in clinical practice. Agnostic of technology but esteemed faculty discussing experience with all FT devices. #AUA24
Behfar Ehdaie tweet media
English
1
6
37
4K
Behfar Ehdaie
Behfar Ehdaie@BehfarEhdaieMD·
@ProtonStorey @DrSpratticus And, do these “reclassified” cancers detected with adv bx techniques impact oncologic outcomes. As you mentioned, rad onc prospective trials are reassuring. And, 10yr+ registry data in focal therapy also reporting >95% metastases free and >98% survival data @LondonProstate1
English
3
1
1
1.3K
Behfar Ehdaie
Behfar Ehdaie@BehfarEhdaieMD·
@ProtonStorey @DrSpratticus Fair points Mark. We should continue to push and improve outcomes in this emerging treatment modality. Thought provoking: we observed 25% misclassification on initial bx (high vol, MR/Bx) -how many patients referred to radiation onc are undertreated based on biopsy tx planning?
English
2
0
2
1.2K
Daniel E Spratt
Daniel E Spratt@DrSpratticus·
One of many sessions showing #AUA24 endorsing this non EBM treatment to the point they discuss focal as something to add to your armamentarium rather than get evidence to support its use, FDA approval, payer and guideline support, and most importantly, patient benefit. Come on AUA. One thing to remain silent (which was unfortunate), another to build out dozens of sessions/days on this. Awesome for women to gather, just wish it was for something to help patients (cystectomy, nephrectomy, RPLND, etc).
Rafael Sanchez-Salas@RSanchez_Salas

- "Women in Focal Therapy." A gathering with a great objective. Happening at #AUA24 Unique initiative by @KaraWattsMD @FocalSociety @AmerUrological @Uroweb

Shaker Heights, OH 🇺🇸 English
6
6
28
28K
Behfar Ehdaie
Behfar Ehdaie@BehfarEhdaieMD·
@DrSpratticus Can we improve- absolutely. 1. Better techniques in systematic and targeted biopsy 2. Reduce heterogeneity of MRI across hospitals 3. Compare treatment modalities / focus on increasing treatment area and energy 4. Incorporate/study tissue (urine? serum?) biomarkers 5. Trials
English
1
1
1
1.7K
Behfar Ehdaie
Behfar Ehdaie@BehfarEhdaieMD·
@DrSpratticus I am not sure what data you are conflating but if speaking about our multi-center Phase 2 study: 12% >=GG2 PCa recurrence in treated lesion and ~25% GG2 detected in the untreated region (eg opposite hemigland) on “2” year biopsy. No stress urinary incontinence. 10% ED IIEF <24.
English
2
2
7
12.5K
Behfar Ehdaie
Behfar Ehdaie@BehfarEhdaieMD·
@rovingatuscap @UrologyMSK @GU_Path_Society @MSKCancerCenter @LotanLab @FionaMacPath @evacomperat @daniel_berney @h_alahmadie @fadbrimo @eugene_pietzak @JieFuChen2 @AmerUrological Thank you for the invitation from #USCAPS for the opportunity to present almost 10yrs of work demonstrating the value de-escalating care in prostate cancer and rethinking the Gleason Grade system that incorporates proportions of patterns vs relying on quantification
English
0
2
7
833
Behfar Ehdaie
Behfar Ehdaie@BehfarEhdaieMD·
@RTendulkarMD @m_e_nielsen In my experience, the correction is minor and helpful in cases in which PSA is 0.05 -> 0.1. Perhaps, lab error could have contributed to this case- a more common clinical situation.
English
0
0
2
347
Rahul Tendulkar, MD
Rahul Tendulkar, MD@RTendulkarMD·
Ever had a case of spurious postop PSA elevation that didn’t make sense? Hint: recheck the PSA with human anti-mouse antibody (HAMA) treatment. Here’s a case where a patient was spared from unnecessary salvage therapy.
English
13
45
140
0

Keşfet

@marthpodi @ChiUroSociety @dipenjparekh @gonzomdphd @AmirLebastchi @USC_Urology @FocalOneHIFU @nyulangone